CRT 2026
Coronary
Ankur Kalra, MD
Division Chief of Cardiology
State University of New York (SUNY) Upstate Medical Center University, New York, United States
Disclosure(s): No financial relationships to disclose
Rony Lahoud, MD
Associate Professor
University of Vermont
S. Burlington, Vermont, United States
Disclosure information not submitted.
Sameer Mehta, MD
Chairman
Lumen Foundation
Miami, Florida, United States
Disclosure(s): No financial relationships to disclose
Davide Capodanno, MD, PhD
Full Professor
Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania
Catania, Sicilia, Italy
Disclosure(s): Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
C. Michael Gibson, MD
Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure information not submitted.
Rajiv Gulati, MD, PhD
Chair, Division of Interventional Cardiology
Mayo Clinic
Rochester, Minnesota, United States
Disclosure(s): No financial relationships to disclose
Krishnaraj S. Rathod, MBBS, BMedSci (Hons), MRCP (UK), PhD, FHEA, QDip, PGDip, MSc, FESC
Interventional Cardiology Consultant
Bart Heart Centre, St. Bartholomew's Hospital
London, England, United Kingdom
Disclosure(s): No financial relationships to disclose
Yasser Sammour, MD, MSc
Interventional Cardiology Fellow
Emory University School of Medicine
Disclosure(s): No financial relationships to disclose
Pieter C. Smits, PhD, FESC
Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands
Disclosure information not submitted.
Ji Young Park, MD, PhD
Professor
Nowon Eulji Medical Center, Eulji University
Seoul, Seoul-t'ukpyolsi, Republic of Korea
Disclosure(s): No financial relationships to disclose